158 related articles for article (PubMed ID: 2731776)
1. Elevated fibrin D-dimer fragment in sickle cell anemia: evidence for activation of coagulation during the steady state as well as in painful crisis.
Francis RB
Haemostasis; 1989; 19(2):105-11. PubMed ID: 2731776
[TBL] [Abstract][Full Text] [Related]
2. Fragment D-dimer levels: an objective marker of vaso-occlusive crisis and other complications of sickle cell disease.
Devine DV; Kinney TR; Thomas PF; Rosse WF; Greenberg CS
Blood; 1986 Jul; 68(1):317-9. PubMed ID: 3719103
[TBL] [Abstract][Full Text] [Related]
3. Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: a brief report.
Ahmed S; Siddiqui AK; Iqbal U; Sison CP; Shahid RK; Sheth M; Patel DV; Russo LA
Eur J Haematol; 2004 Mar; 72(3):213-6. PubMed ID: 14962240
[TBL] [Abstract][Full Text] [Related]
4. Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease.
Francis RB; Haywood LJ
J Natl Med Assoc; 1992 Jul; 84(7):611-5. PubMed ID: 1629925
[TBL] [Abstract][Full Text] [Related]
5. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients.
Kurantsin-Mills J; Ofosu FA; Safa TK; Siegel RS; Lessin LS
Br J Haematol; 1992 Aug; 81(4):539-44. PubMed ID: 1390242
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of inflammation, growth factor, and coagulation activation in patients with sickle cell disease.
Qari MH; Dier U; Mousa SA
Clin Appl Thromb Hemost; 2012; 18(2):195-200. PubMed ID: 21949038
[TBL] [Abstract][Full Text] [Related]
7. Relevance of fibrinolytic protein (D-dimer) and fibrinopeptide A as markers of sickle cell anaemia vaso-occlusive crisis.
Ekwere TA; Ebele U; Ekanem M; Ogunro PS
Niger Postgrad Med J; 2014 Sep; 21(3):225-30. PubMed ID: 25331238
[TBL] [Abstract][Full Text] [Related]
8. Heamostatic and genetic predisposing factors for stroke in children with sickle cell anemia.
Mourad H; Fadel W; El Batch M; Rowisha M
Egypt J Immunol; 2008; 15(1):25-37. PubMed ID: 20306667
[TBL] [Abstract][Full Text] [Related]
9. Coagulation changes during the steady state in homozygous sickle-cell disease in Jamaica.
Leslie J; Langler D; Serjeant GR; Serjeant BE; Desai P; Gordon YB
Br J Haematol; 1975 Jun; 30(2):159-66. PubMed ID: 1201207
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
[TBL] [Abstract][Full Text] [Related]
11. Raised D-dimer levels in acute sickle cell crisis and their correlation with chest X-ray abnormalities.
Dar J; Mughal I; Hassan H; Al Mekki TE; Chapunduka Z; Hassan IS
Ger Med Sci; 2010 Oct; 8():Doc25. PubMed ID: 21063468
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor-positive monocytes expression in children with sickle cell disease: clinical implication and relation to inflammatory and coagulation markers.
Ragab SM; Soliman MA
Blood Coagul Fibrinolysis; 2016 Dec; 27(8):862-869. PubMed ID: 26761587
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease.
Nsiri B; Gritli N; Bayoudh F; Messaoud T; Fattoum S; Machghoul S
Hematol Cell Ther; 1996 Jul; 38(3):279-84. PubMed ID: 8974793
[TBL] [Abstract][Full Text] [Related]
14. Role of D dimer in patients with elevated fibrinogen degradation products in serum: further study in chronic myelogenous leukemia.
Saito M; Asakura H; Jokaji H; Uotanzi C; Kumabashiri I; Yoshida T; Hashizume K; Matsuda T
Acta Haematol; 1990; 84(3):149-55. PubMed ID: 2123066
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the hypercoagulable state in patients with sickle cell disease.
Shah N; Thornburg C; Telen MJ; Ortel TL
Thromb Res; 2012 Nov; 130(5):e241-5. PubMed ID: 22959127
[TBL] [Abstract][Full Text] [Related]
16. Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke.
Hyacinth HI; Adams RJ; Greenberg CS; Voeks JH; Hill A; Hibbert JM; Gee BE
PLoS One; 2015; 10(8):e0134193. PubMed ID: 26305570
[TBL] [Abstract][Full Text] [Related]
17. Fibrin D-dimer in thrombogenic disorders.
Matsuo T; Kobayashi H; Kario K; Suzuki S
Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis.
Nur E; van Beers EJ; Martina S; Cuccovillo I; Otten HM; Schnog JJ; Meijers JC; Mantovani A; Brandjes DP; Bottazzi B; Biemond BJ;
Blood Cells Mol Dis; 2011 Mar; 46(3):189-94. PubMed ID: 21256776
[TBL] [Abstract][Full Text] [Related]
19. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
Horan JT; Francis CW
Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of hypercoagulability change in steady state and during vaso-occlusive crisis among Sudanese patients living with sickle cell disease.
Mohamed EA; Elgari MM; Babker AM; Waggiallah HA
Afr Health Sci; 2020 Mar; 20(1):392-396. PubMed ID: 33402927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
